Literature DB >> 3031660

Interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptors.

R J Robb, C M Rusk, J Yodoi, W C Greene.   

Abstract

Interleukin 2 (IL-2) receptors on activated T cells exist in high- and low-affinity configurations, both of which share a ligand-binding component known as the Tac protein. Although almost all binding of IL-2 to such cells was inhibited by an antibody to Tac, the predominant component of binding on the natural killer (NK)-like cell line YT was resistant to this reagent. The ligand-binding component on YT cells also differed from Tac in its affinity constant (Kd approximately 8.2 X 10(-10) M vs. Kd approximately equal to 1.1 X 10(-8) M for low-affinity Tac sites) and in its susceptibility to inhibition by certain antibodies to IL-2. When the YT cells were stimulated in a manner that induced expression of the Tac protein, the IL-2 binding sites were converted to a high-affinity configuration (Kd approximately 1.8 X 10(-11) M). Thus, the original binding component on unstimulated YT cells appeared to combine with Tac and IL-2 to produce a high-affinity receptor complex. Use of bifunctional crosslinking agents following ligand binding to unstimulated YT cells yielded covalent IL-2-receptor complexes of 83 and 90 kDa. These complexes were similar in size to those derived from high-affinity receptors on activated T cells and shared a similar fragmentation pattern upon proteolysis. These results demonstrate the existence of a second IL-2 binding component in addition to the Tac protein and suggest that this component combines with Tac and IL-2 to form high-affinity receptor sites.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3031660      PMCID: PMC304571          DOI: 10.1073/pnas.84.7.2002

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex.

Authors:  M Tsudo; R W Kozak; C K Goldman; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

2.  TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells).

Authors:  J Yodoi; K Teshigawara; T Nikaido; K Fukui; T Noma; T Honjo; M Takigawa; M Sasaki; N Minato; M Tsudo
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

3.  A monoclonal antibody 7G7/B6, binds to an epitope on the human interleukin-2 (IL-2) receptor that is distinct from that recognized by IL-2 or anti-Tac.

Authors:  L A Rubin; C C Kurman; W E Biddison; N D Goldman; D L Nelson
Journal:  Hybridoma       Date:  1985

4.  Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.

Authors:  J R Ortaldo; A T Mason; J P Gerard; L E Henderson; W Farrar; R F Hopkins; R B Herberman; H Rabin
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

5.  A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor.

Authors:  W J Leonard; J M Depper; T Uchiyama; K A Smith; T A Waldmann; W C Greene
Journal:  Nature       Date:  1982-11-18       Impact factor: 49.962

6.  Regions of complementarity between the messenger RNAs for epidermal growth factor, transferrin, interleukin-2 and their respective receptors.

Authors:  K L Bost; E M Smith; J E Blalock
Journal:  Biochem Biophys Res Commun       Date:  1985-05-16       Impact factor: 3.575

7.  Stimulation of immunoglobulin secretion in human B lymphocytes as a direct effect of high concentrations of IL 2.

Authors:  P Ralph; G Jeong; K Welte; R Mertelsmann; H Rabin; L E Henderson; L M Souza; T C Boone; R J Robb
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

8.  Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen.

Authors:  R J Robb; W C Greene; C M Rusk
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

9.  Studies of structure-activity relationships of human interleukin-2.

Authors:  S M Liang; D R Thatcher; C M Liang; B Allet
Journal:  J Biol Chem       Date:  1986-01-05       Impact factor: 5.157

10.  Reconstitution of functional receptor for human interleukin-2 in mouse cells.

Authors:  M Hatakeyama; S Minamoto; T Uchiyama; R R Hardy; G Yamada; T Taniguchi
Journal:  Nature       Date:  1985 Dec 5-11       Impact factor: 49.962

View more
  68 in total

1.  Flow cytometry resonance energy transfer suggests an association between low-affinity interleukin 2 binding sites and HLA class I molecules.

Authors:  A Harel-Bellan; P Krief; L Rimsky; W L Farrar; Z Mishal
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

2.  Immunological and structural homology between human T-cell leukemia virus type I envelope glycoprotein and a region of human interleukin-2 implicated in binding the beta receptor.

Authors:  D S Kohtz; A Altman; J D Kohtz; S Puszkin
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

3.  Novel interleukin 2 (IL-2) receptor appears to mediate IL-2-induced activation of natural killer cells.

Authors:  J H Kehrl; M Dukovich; G Whalen; P Katz; A S Fauci; W C Greene
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

4.  Interleukin-2 Receptor β Thr-450 Phosphorylation Is a Positive Regulator for Receptor Complex Stability and Activation of Signaling Molecules.

Authors:  Blanca E Ruiz-Medina; Jeremy A Ross; Robert A Kirken
Journal:  J Biol Chem       Date:  2015-07-07       Impact factor: 5.157

Review 5.  Surface proteins and glycoproteins of human leucocytes.

Authors:  V Horejsí; V Bazil
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

6.  Demonstration of two distinct forms of released low affinity-type rat IL-2 receptors.

Authors:  T Herrmann; O Josimovic-Alasevic; A Mouzaki; T Diamantstein
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

7.  Abnormal intracellular sorting of O-linked carbohydrate-deficient interleukin-2 receptors.

Authors:  K F Kozarsky; S M Call; S K Dower; M Krieger
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

8.  Identification of a direct interaction between interleukin 2 and the p64 interleukin 2 receptor gamma chain.

Authors:  S D Voss; T P Leary; P M Sondel; R J Robb
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

9.  Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptors.

Authors:  L H Elliott; W H Brooks; T L Roszman
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

10.  Evidence for additional subunits associated to the mouse interleukin 2 receptor p55/p75 complex.

Authors:  H Saragovi; T R Malek
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.